v3.26.1
Segment Reporting
3 Months Ended
Mar. 31, 2026
Segment Reporting  
Segment Reporting

13.  Segment Reporting

We report segment information based on the various industries in which our businesses operate and how we manage those businesses in accordance with our investment strategies, which may include: identifying and acquiring undervalued assets and businesses, often through the purchase of distressed securities; increasing value through management, financial or other operational changes; and managing complex legal, regulatory or financial issues, which may include bankruptcy or insolvency, environmental, zoning, permitting and licensing issues. Therefore, although many of our businesses are operated under separate local management, certain of our businesses are grouped together when they operate within a similar industry, comprising similarities in products, customers, production processes and regulatory environments, and when such businesses, when considered together, may be managed in accordance with one or more investment strategies specific to those businesses.

Our reportable segments reflect the way the Company is managed, and for which separate financial information is available and evaluated regularly by the Company’s Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources and assess performance. The Chairman of the Board of Directors of our general partner, who is our CODM, reviews financial information for each segment and evaluates the results in relation to our broader business strategies. Accordingly, segment operating results are assessed based on net income from continuing operations attributable to Icahn Enterprises. Assets provided to the CODM are consistent with those reported in the condensed consolidated balance sheets, and there are no intra-entity sales or transfers, or significant expense categories regularly reviewed by the CODM beyond those disclosed in the condensed consolidated statements of operations.

Condensed Statements of Operations

Three Months Ended March 31, 2026

  ​ ​ ​

Investment

  ​ ​ ​

Energy

  ​ ​ ​

Automotive

  ​ ​ ​

Food Packaging

  ​ ​ ​

Real Estate

  ​ ​ ​

Home Fashion

  ​ ​ ​

Pharma

  ​ ​ ​

Holding Company

  ​ ​ ​

Consolidated

(in millions)

Revenues:

Net sales

$

$

1,980

$

187

$

87

$

3

$

39

$

15

$

$

2,311

Other revenues from operations

 

 

 

142

 

 

18

 

 

1

 

 

161

Net loss from investment activities

 

(300)

 

 

 

 

 

 

 

(2)

 

(302)

Interest and dividend income

 

31

 

5

 

 

 

4

 

 

 

7

 

47

Loss on disposition of assets, net

 

 

(1)

 

(1)

 

 

 

 

 

 

(2)

Other loss (income), net

 

 

(17)

 

 

1

 

7

 

 

 

 

(9)

 

(269)

 

1,967

 

328

 

88

 

32

 

39

 

16

 

5

 

2,206

Expenses:

Cost of goods sold

 

 

2,095

 

123

 

78

 

3

 

32

 

9

 

 

2,340

Other expenses from operations

 

 

 

122

 

 

19

 

 

 

 

141

Dividend expense

 

5

 

 

 

 

 

 

 

 

5

Selling, general and administrative

 

4

 

47

 

109

 

13

 

5

 

10

 

14

 

7

 

209

Interest expense

 

1

 

31

 

1

 

3

 

 

1

 

 

86

 

123

 

10

 

2,173

 

355

 

94

 

27

 

43

 

23

 

93

 

2,818

(Loss) income before income tax benefit

 

(279)

 

(206)

 

(27)

 

(6)

 

5

 

(4)

 

(7)

 

(88)

 

(612)

Income tax benefit (expense)

 

 

33

 

7

 

(1)

 

 

 

 

10

 

49

Net (loss) income

 

(279)

 

(173)

 

(20)

 

(7)

 

5

 

(4)

 

(7)

 

(78)

 

(563)

Less: net (loss) income attributable to non-controlling interests

 

(69)

 

(34)

 

 

(1)

 

 

 

 

 

(104)

Net (loss) income attributable to Icahn Enterprises

$

(210)

$

(139)

$

(20)

$

(6)

$

5

$

(4)

$

(7)

$

(78)

$

(459)

Supplemental information:

Capital expenditures

$

$

47

$

47

$

9

$

10

$

1

$

$

$

114

Depreciation and amortization

$

$

96

$

12

$

4

$

8

$

1

$

2

$

$

123

Three Months Ended March 31, 2025

  ​ ​ ​

Investment

  ​ ​ ​

Energy

  ​ ​ ​

Automotive

  ​ ​ ​

Food Packaging

  ​ ​ ​

Real Estate

  ​ ​ ​

Home Fashion

  ​ ​ ​

Pharma

  ​ ​ ​

Holding Company

  ​ ​ ​

Consolidated

(in millions)

Revenues:

Net sales

$

$

1,646

$

198

$

94

$

$

41

$

23

$

$

2,002

Other revenues from operations

 

 

 

151

 

 

17

 

 

 

 

168

Net loss from investment activities

 

(394)

 

 

 

 

 

 

 

 

(394)

Interest and dividend income

 

55

 

10

 

1

 

 

 

 

 

17

 

83

Gain on disposition of assets, net

 

 

(1)

 

(2)

 

 

 

 

 

 

(3)

Other income, net

 

7

 

2

 

 

2

 

 

(1)

 

1

 

 

11

 

(332)

 

1,657

 

348

 

96

 

17

 

40

 

24

 

17

 

1,867

Expenses:

Cost of goods sold

 

 

1,748

 

144

 

80

 

 

31

 

13

 

 

2,016

Other expenses from operations

 

 

 

135

 

 

16

 

 

 

 

151

Dividend expense

 

8

 

 

 

 

 

 

 

 

8

Selling, general and administrative

 

4

 

44

 

105

 

12

 

5

 

11

 

13

 

7

 

201

Impairment

10

10

Restructuring, net

7

7

Interest expense

6

 

35

 

1

 

3

 

 

 

 

83

 

128

 

18

 

1,827

 

385

 

112

 

21

 

42

 

26

 

90

 

2,521

(Loss) income before income tax (expense) benefit

 

(350)

 

(170)

 

(37)

 

(16)

 

(4)

 

(2)

 

(2)

 

(73)

 

(654)

Income tax (expense) benefit

 

 

53

 

10

 

2

 

 

 

 

9

 

74

Net (loss) income

 

(350)

 

(117)

 

(27)

 

(14)

 

(4)

 

(2)

 

(2)

 

(64)

 

(580)

Less: net (loss) income attributable to non-controlling interests

 

(126)

 

(31)

 

 

(1)

 

 

 

 

 

(158)

Net (loss) income attributable to Icahn Enterprises

$

(224)

$

(86)

$

(27)

$

(13)

$

(4)

$

(2)

$

(2)

$

(64)

$

(422)

Supplemental information:

Capital expenditures

$

$

51

$

24

$

7

$

4

$

2

$

$

$

88

Depreciation and amortization

$

$

84

$

17

$

5

$

4

$

1

$

7

$

$

118

Disaggregation of Revenue

In addition to the condensed statements of operations by reporting segment above, we provide additional disaggregated revenue information for our Energy and Automotive segments below.

Energy

Three Months Ended March 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

Petroleum products

1,800

$

1,475

Nitrogen fertilizer products

180

143

Other

 

 

28

$

1,980

$

1,646

Automotive

Three Months Ended March 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

Automotive Services

$

324

$

333

Aftermarket Parts

2

Total revenue from customers

324

335

Lease revenue outside the scope of ASC 606

5

14

Total Automotive net sales and other revenues from operations

$

329

$

349

Condensed Balance Sheets

March 31, 2026

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

16

$

512

$

51

$

29

$

35

$

5

$

27

$

624

$

1,299

Cash held at consolidated affiliated partnerships and restricted cash

 

1,818

 

 

8

 

 

 

2

 

 

167

 

1,995

Investments

 

1,530

 

13

 

 

 

95

 

 

 

 

1,638

Accounts receivable, net

 

 

329

 

24

 

63

 

11

 

27

 

27

 

 

481

Related party note receivable

132

132

Inventories, net

 

 

553

 

163

 

99

 

 

90

 

22

 

 

927

Property, plant and equipment, net

 

 

2,309

 

363

 

143

 

761

 

55

 

 

3

 

3,634

Goodwill and intangible assets, net

 

 

134

 

314

 

21

 

 

21

 

140

 

 

630

Other assets

 

948

 

418

 

375

 

78

 

110

 

15

 

6

 

247

 

2,197

Total assets

$

4,312

$

4,268

$

1,298

$

433

$

1,144

$

215

$

222

$

1,041

$

12,933

LIABILITIES AND EQUITY

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

Accounts payable, accrued expenses and other liabilities

$

675

$

1,374

$

721

$

107

$

29

$

39

$

61

$

440

$

3,446

Securities sold, not yet purchased, at fair value

 

748

 

 

 

 

 

 

 

 

748

Debt

 

 

1,784

 

26

 

131

 

1

 

25

 

 

4,425

 

6,392

Total liabilities

 

1,423

 

3,158

 

747

 

238

 

30

 

64

 

61

 

4,865

 

10,586

Equity attributable to Icahn Enterprises

 

2,221

 

589

 

551

 

184

 

1,114

 

151

 

161

 

(3,824)

 

1,147

Equity attributable to non-controlling interests

 

668

 

521

 

 

11

 

 

 

 

 

1,200

Total equity

 

2,889

 

1,110

 

551

 

195

 

1,114

 

151

 

161

 

(3,824)

 

2,347

Total liabilities and equity

$

4,312

$

4,268

$

1,298

$

433

$

1,144

$

215

$

222

$

1,041

$

12,933

December 31, 2025

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

16

$

511

$

14

$

9

$

31

$

4

$

26

$

839

$

1,450

Cash held at consolidated affiliated partnerships and restricted cash

 

1,788

 

 

8

 

 

 

3

 

 

170

 

1,969

Investments

 

2,146

 

17

 

 

 

88

 

 

 

 

2,251

Accounts receivable, net

 

 

235

 

25

 

60

 

10

 

27

 

36

 

 

393

Related party notes receivable, net

129

129

Inventories, net

 

 

472

 

165

 

97

 

 

87

 

24

 

 

845

Property, plant and equipment, net

 

 

2,333

 

351

 

141

 

787

 

55

 

 

3

 

3,670

Goodwill and intangible assets, net

 

 

139

 

316

 

21

 

 

21

 

142

 

 

639

Other assets

 

1,661

 

422

 

369

 

79

 

79

 

15

 

8

 

236

 

2,869

Total assets

$

5,611

$

4,129

$

1,248

$

407

$

1,124

$

212

$

236

$

1,248

$

14,215

LIABILITIES AND EQUITY

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

Accounts payable, accrued expenses and other liabilities

$

606

$

1,079

$

772

$

117

$

32

$

34

$

67

$

84

$

2,791

Securities sold, not yet purchased, at fair value

 

1,382

 

 

 

 

 

 

 

 

1,382

Debt

 

 

1,765

 

21

 

142

 

1

 

23

 

 

4,664

 

6,616

Total liabilities

 

1,988

 

2,844

 

793

 

259

 

33

 

57

 

67

 

4,748

 

10,789

Equity attributable to Icahn Enterprises

 

2,711

 

722

 

455

 

139

 

1,091

 

155

 

169

 

(3,500)

 

1,942

Equity attributable to non-controlling interests

 

912

 

563

 

 

9

 

 

 

 

 

1,484

Total equity

 

3,623

 

1,285

 

455

 

148

 

1,091

 

155

 

169

 

(3,500)

 

3,426

Total liabilities and equity

$

5,611

$

4,129

$

1,248

$

407

$

1,124

$

212

$

236

$

1,248

$

14,215